来自FDA不良事件报告系统 (FAERS) 数据库的环素的现实世界不成比例分析
Shichao Cui1, Li Li1, Wensheng Liu1
1NHC Key Laboratory of Male Reproduction and Genetics, Guangdong Provincial Reproductive Science Institute (Guangdong Provincial Fertility Hospital), Guangzhou, China.
概括
这项研究通过分析不良事件,确定了免疫抑制剂环素的新安全问题. 发现了新的药物不良反应,为更安全的患者使用提供了关键的见解.
科学领域:
- 药监和药物安全 药监和药物安全
- 免疫学和移植医学 免疫学和移植医学
- 临床药理学 临床药理学
背景情况:
- 环素是预防器官移植排斥的重要免疫抑制剂.
- 评估环素的安全性对患者护理至关重要.
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 是药物监测的关键资源.
研究的目的:
- 通过分析FAERS数据库中的不良事件 (AE) 来评估环素的安全性.
- 为了确定已知的和新的潜在的药物不良反应 (ADRs) 与环素相关.
- 为临床使用环素提供最新的安全信息.
主要方法:
- 在FAERS数据库 (2013-2022) 中使用药监分析,有19,582份病例报告.
- 采用了四种算法:报告赔率比率 (ROR),比例报告比率 (PRR),贝叶斯信心传播神经网络 (BCPNN) 和经验贝叶斯几何平均值 (EBGM).
- 分析了3,911个已识别的副作用,其中476个与环素作为27个器官系统类 (SOC) 中的主要疑似药物有关.
主要成果:
- 与眼睛疾病,免疫系统疾病以及损伤/中毒/手术并发症相关的已知确认的副作用,符合环素标签.
- 发现了新的潜在副作用,包括肝胆道疾病.
- 识别了未在环素标签上列出的意想不到的不良反应,例如胆道缩并发症和精子细胞渐进性运动性降低.
结论:
- 在FAERS的药监测分析中,发现了对环素的新的和意想不到的潜在副作用.
- 这些发现凸显了更新安全信息和标签修订的必要性.
- 这项研究为循环氨酸的适当临床应用提供了宝贵的安全见解.
相关概念视频
01:11Renal Failure: Dose Adjustments
77
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
77
01:19Pharmacovigilance
805
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
805